Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2007, Vol. 109, No. 5, pp. 2023-2031.
Prepublished online as a Blood First Edition Paper on October 31, 2006; DOI 10.1182/blood-2006-05-021600.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-05-021600v1
109/5/2023    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frohlich, A.
Right arrow Articles by Kopf, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frohlich, A.
Right arrow Articles by Kopf, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted May 9, 2006
Accepted October 10, 2006

IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo

Anja Frohlich, Benjamin J Marsland, Ivo Sonderegger, Michael Kurrer, Martin R Hodge, Nicola L Harris, and Manfred Kopf*

Institute of Integrative Biology, Molecular Biomedicine, ETH Zurich, Switzerland
Dept of Pathology, University Zurich, Switzerland
Inflammation Division, Millenium Pharmaceuticals, Inc., Cambridge, MA, United States
Institute of Integrative Biology, Environmental Biomedicine, ETH Zurich, Switzerland

* Corresponding author; email: manfred.kopf{at}ethz.ch.

Interleukin 21 (IL-21) is a member of the common {gamma}-chain family of cytokines, which influence a broad spectrum of immunological responses. A number of studies have examined the function of IL-21; however, its specific role in Th1/ Th2 cell differentiation and related effector responses remains to be clarified. Thus, we generated IL-21R-deficient mice and have investigated the role of IL-21R signaling using a series of in vivo experimentally induced disease models. We first addressed the role of IL-21R signaling in Th2 immune responses by examining allergic airway inflammation, Nippostrongylus brasiliensis and Heligomosomoides polygyrus anti-helminth responses. In each of these systems, IL-21R signaling played a clear role in the development of Th2 responses. Comparatively, IL-21R signaling was not required for the containment of Leishmania major infection, or the development of experimental autoimmune myocarditis, indicative of competent Th1 and Th17 responses, respectively. Adoptive transfer of T cells and analysis of IL-21R+/+:-/- chimera mice revealed that IL-21R-signaling was central to Th2 cell survival or migration to peripheral tissues. Overall, our data shows IL-21 plays a crucial role in supporting polarized Th2 responses in vivo, whilst appearing superfluous for Th1 and Th17 responses.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020